AstraZeneca, Merck face potential class action over heartburn drugs

Class Actions 2024-07-29 2:57 pm
A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.
For information on rights and reprints, contact subscriptions@lawyerly.com.au